SCHOTT Pharma
Filipe Foresto de M. Merli has a diverse work experience. Filipe has worked at SCHOTT Pharma since 2018, where they served as the Head of Quality Systems and Processes. Prior to that, they worked at SCHOTT do Brasil from 2016 to 2018 as the QEHS Manager. From 2014 to 2018, they held the position of Regional Head of Quality - South America at SCHOTT. Before joining SCHOTT, Merli worked at SCHOTT do Brasil Ltda. - Divisão Embalagens from 2009 to 2016, starting as a Trainee/Graduate and later becoming the Quality Manager (Control, Assurance). Filipe began their career at Comgas in 2007 as a Maintenance intern - Mechanical Engineering. In 2006, they were the Captain of the FSAE Unicamp Team.
Filipe Foresto de M. Merli completed their Bachelor's degree in Mechanical Engineering from the Universidade Estadual de Campinas from 2003 to 2008. Filipe pursued further education and completed a Master of Business Administration (MBA) degree in Quality Engineering and Management from PECE - Escola Politécnica da USP in 2011 to 2012. In 2015, they obtained a Black Belt certification in Lean Six Sigma from Fundação Vanzolini, specializing in Lean Six Sigma methodologies.
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social